Cargando…

A breast cancer gene signature for indolent disease

PURPOSE: Early-stage hormone-receptor positive breast cancer is treated with endocrine therapy and the recommended duration of these treatments has increased over time. While endocrine therapy is considered less of a burden to patients compared to chemotherapy, long-term adherence may be low due to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delahaye, Leonie J. M. J., Drukker, Caroline A., Dreezen, Christa, Witteveen, Anke, Chan, Bob, Snel, Mireille, Beumer, Inès J., Bernards, Rene, Audeh, M. William, van’t Veer, Laura J., Glas, Annuska M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487706/ https://www.ncbi.nlm.nih.gov/pubmed/28451965 http://dx.doi.org/10.1007/s10549-017-4262-0

Ejemplares similares

Equivalence of MammaPrint array types in clinical trials and diagnostics
por: Beumer, Inès, et al.
Publicado: (2016)

Prognostic Value of MammaPrint(®) in Invasive Lobular Breast Cancer
por: Beumer, Inès J., et al.
Publicado: (2016)

A Computational Workflow Translates a 58-Gene Signature to a Formalin-Fixed, Paraffin-Embedded Sample-Based Companion Diagnostic for Personalized Treatment of the BRAF-Mutation-Like Subtype of Colorectal Cancers
por: In’t Veld, Sjors G. J. G., et al.
Publicado: (2017)

Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test()
por: Mittempergher, Lorenza, et al.
Publicado: (2020)

Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial
por: Jacob, Laurent, et al.
Publicado: (2020)

Converting a breast cancer microarray signature into a high-throughput diagnostic test
por: Glas, Annuska M, et al.
Publicado: (2006)

Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer
por: Tian, Sun, et al.
Publicado: (2010)

A gene expression profile for detection of sufficient tumour cells in breast tumour tissue: microarray diagnosis eligibility
por: Roepman, Paul, et al.
Publicado: (2009)

A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction
por: Tian, Sun, et al.
Publicado: (2013)

Long-term impact of the 70-gene signature on breast cancer outcome
por: Drukker, C. A., et al.
Publicado: (2014)

High concordance of 70‐gene recurrence risk signature and 80‐gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early‐stage breast cancer
por: Crozier, Jennifer A., et al.
Publicado: (2021)

Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging
por: Yue, Yong, et al.
Publicado: (2015)

Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools
por: Ach, Robert A, et al.
Publicado: (2007)

MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early‐stage breast cancer patients
por: Haan, Josien C., et al.
Publicado: (2021)

Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients
por: Witteveen, Annemieke, et al.
Publicado: (2015)

Patterns and predictors of first and subsequent recurrence in women with early breast cancer
por: Geurts, Y. M., et al.
Publicado: (2017)

BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance
por: Kuilman, Midas M., et al.
Publicado: (2022)

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk
por: van ‘t Veer, Laura J., et al.
Publicado: (2017)

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
por: Severson, Tesa M., et al.
Publicado: (2017)

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance
por: Viale, Giuseppe, et al.
Publicado: (2016)

Contralateral breast cancer risk in relation to tumor morphology and age—in which patients is preoperative MRI justified?
por: de Glas, N. A., et al.
Publicado: (2015)

The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
por: Waaijer, M. E.C., et al.
Publicado: (2023)

Comparison of the diagnostic workup of women referred at non-blinded or blinded double reading in a population-based screening mammography programme in the south of the Netherlands
por: Weber, Roy J P, et al.
Publicado: (2015)

Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris
por: Slembrouck, Laurence, et al.
Publicado: (2019)

Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer
por: de Boer, Anna Z., et al.
Publicado: (2019)

Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study
por: de Glas, Nienke, et al.
Publicado: (2019)

Prognostic factors for recovery of health status after injury: a prospective multicentre cohort study
por: de Munter, Leonie, et al.
Publicado: (2021)

Application of the urban exposome framework using drinking water and quality of life indicators: a proof-of-concept study in Limassol, Cyprus
por: Andrianou, Xanthi D., et al.
Publicado: (2019)

Healthy Ageing and Intellectual Disability study: summary of findings and the protocol for the 10-year follow-up study
por: de Leeuw, Marleen J, et al.
Publicado: (2022)

Impact of dietary patterns and the main food groups on mortality and recurrence in cancer survivors: a systematic review of current epidemiological literature
por: Jochems, Sylvia H J, et al.
Publicado: (2018)

Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison
por: de Boer, Anna Z., et al.
Publicado: (2020)

Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study
por: Winter, Anke C, et al.
Publicado: (2012)

Prospective comorbidity-matched study of Parkinson's disease and risk of mortality among women
por: Winter, Anke C, et al.
Publicado: (2016)

Implant Materials Generate Different Peri-implant Inflammatory Factors: Poly-ether-ether-ketone Promotes Fibrosis and Microtextured Titanium Promotes Osteogenic Factors
por: Olivares-Navarrete, Rene, et al.
Publicado: (2015)

Predictive value of mucinous histology in colon cancer: a population-based, propensity score matched analysis
por: Warschkow, Rene, et al.
Publicado: (2016)

Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

Men who have sex with men in Great Britain: comparing methods and estimates from probability and convenience sample surveys
por: Prah, Philip, et al.
Publicado: (2016)

Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study
por: Abrahami, Devin, et al.
Publicado: (2020)

A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort
por: Dubsky, P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ar1fpb0seval55u1i6mueqli96